anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

180,781-180,840 of 319,975

filter-aware
08
The slide uses photographic evidence to demonstrate operational progress.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Beat · SolutionLoop · Zoom In1 hit
09
The slide uses aerial photography to demonstrate physical construction progress.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Beat · SolutionLoop · Zoom In1 hit
10
Four photos showing site preparation and electrical substation equipment.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
11
Visual proof of project execution status.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations 1 hit
12
Cipher Mining | Investor Presentation Deck | 19 slidesCipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Beat · Market Size1 hit
13
Standard financial statement presentation.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Beat · Financials1 hit
14
The table displays costs, expenses, operating loss, other income, net loss, and per-share data.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Beat · Financials1 hit
15
Contains three distinct financial reconciliation tables.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Beat · Financials1 hit
16
Cipher Mining | Investor Presentation Deck | 19 slidesCipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Beat · Financials1 hit
17
Standard financial reporting table format.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Beat · Financials1 hit
18
The table includes supplemental disclosures for non-cash investing and financing activities.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Beat · Financials1 hit
19
Cipher Mining | Investor Presentation Deck | 19 slidesCipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations 1 hit
01
Slide 1
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
02
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
03
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide is divided into Senior Executive Team (CEO, COO, CSO, CMC, VPs) and Board of Directors.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style layout to track clinical phases and regulatory milestones.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
06
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
07
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide presents key clinical trial results for a drug candidate, focusing on response rates.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
09
Uses the Simon 2-Stage adaptive design framework.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
10
The slide highlights a specific row (2 prior systemic therapies) with a red box.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
11
The chart uses a standard oncology waterfall plot format to visualize tumor shrinkage.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
12
Standard clinical trial swimmer plot showing treatment duration, response (PR/SD), progression (PD), death, and ongoing status.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
13
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
Includes comparative data against FOLFOX and TOPAZ-1.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
Includes a molecular visualization of the antibody-receptor interaction.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
18
The slide uses medical imaging (CT scans) to demonstrate treatment efficacy.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
19
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
21
The slide uses a process flow to show the transition from testing a hypothesis to the identification of the lead candidate CTX-8371, supported by two experimental charts.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
22
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
23
The slide uses a visual legend (checkmarks for completed, stars for in-progress) to track status of specific drug development milestones.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
01
Slide 1
Includes a molecular visualization graphic.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
02
Compass Therapeutics | Investor Presentation Deck | 36 slidesCompass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
03
Compass Therapeutics | Investor Presentation Deck | 36 slidesCompass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
04
The diagram uses visual callouts to map specific cancer locations to their medical terminology.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
05
BTC likely refers to Biliary Tract Cancer.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations 1 hit
06
This slide describes the clinical presentation of a patient, likely related to a biliary or hepatic condition.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
07
The diagram maps patient segments to treatment modalities, showing a progression from resection/adjuvant therapy to palliative care and experimental lines.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
08
This is a standard academic citation slide for a medical journal article.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
09
The diagram illustrates the patient disposition in a clinical trial, a standard methodology for reporting clinical study results.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
10
Data sourced from Valle J et al. N Engl J Med 2010;362:1273-1281.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
11
Includes list of authors and their institutional affiliations.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
12
Clinical trial schema showing randomization of 685 patients into Durvalumab+GemCis or Placebo+GemCis arms.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
13
Clinical trial data presented at ASCO GI22.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
14
Clinical trial data presented at ASCO GI 2022.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
15
Clinical trial data presentation showing bar chart for ORR and Kaplan-Meier curve for DoR.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
16
Clinical context slide likely used to establish the unmet need for second-line treatment options.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
17
The slide highlights the limited progression-free survival (PFS) with a red box around the PFS column.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
18
The slide uses a process flow to illustrate clinical guidelines.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
19
BTC likely stands for Biliary Tract Cancer.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
20
This is a standard academic citation slide.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
21
Standard clinical trial CONSORT flow diagram.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
22
The slide includes a 'Number at risk' table below the chart, which is standard for clinical trial survival analysis.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
23
BTC stands for Biliary Tract Cancer. The slide contrasts established standard-of-care regimens with the lack of efficacy for taxanes.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
24
Compass Therapeutics | Investor Presentation Deck | 36 slidesCompass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
25
Compass Therapeutics | Investor Presentation Deck | 36 slidesCompass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit